Mitochondria Break Down in 5 Specific Places — Here's the Map for Fixing Each One

Every few months a customer asks me some version of the same question: "should I take MOTS-c or NAD+?" And every time, my honest answer is: that's the wrong question.

Your mitochondria are the power plants in every cell in your body, and they don't break down in one generic way. They break down in five specific places, each with a completely different failure mode and a completely different fix. Once you see the map, "MOTS-c or NAD+" stops making sense as a question — they're not competing for the same job. They're different tools for different parts of the machine.

Here's the map.

The 5-part anatomy, at a glance

There is no single best mitochondrial supplement. There are tools that hit different parts of the machine. Knowing which part is failing turns "I bought $400 of supplements and still feel tired" into an actual plan.

Walking the anatomy

Picture a bean with two walls. The outer wall is smooth and porous — it's the front door, letting fuel and signals in. When chronic inflammation or insulin resistance build up over years, that door stiffens. You're not tired because the engine's broken; you're tired because the messages can't get to the engine.

The inner wall is where it gets interesting. It's folded over and over into pleats called cristae — more folds means more surface area for the ATP-making machinery. In young, active mitochondria, those folds are deep and tight. In aged or stressed ones, they flatten out, and the cell makes less ATP per mitochondrion no matter how much fuel shows up. The lipid that holds those folds in shape is cardiolipin, and it's the direct target of SS-31 (elamipretide) — the only FDA-approved peptide in this entire cluster, approved in 2025 for Barth syndrome. SS-31 binds cardiolipin and stabilizes the cristae architecture directly. Think of it as the hardware fix.

Embedded in those cristae folds is the electron transport chain — five stations (imaginatively named complexes I through V) that pass electrons down the line, pump protons across the membrane, and spin a turbine that forges ATP. Complex I is the most damage-prone station, and this is where most of the familiar supplements act. CoQ10 is the electron shuttle between complex I/II and complex III — and it matters more than most people realize if you're on a statin, because statins block the same enzyme pathway (HMG-CoA reductase) that makes cholesterol AND your body's own CoQ10. The best evidence here isn't hand-wavy: the Q-SYMBIO trial gave 420 chronic heart failure patients CoQ10 (100mg, three times daily, two years) and found a 50% reduction in the combined risk of cardiovascular death, hospitalization, or transplant. That's one of the cleanest randomized trial signals in the entire mitochondrial-supplement world. Methylene blue works differently — at low doses it acts as an alternate electron carrier, ferrying electrons around damaged complexes when I or III aren't working well. Real mechanism, but it comes with a hard safety line: it interacts dangerously with SSRIs, SNRIs, and MAOIs (serotonin syndrome risk), so anyone on those medications needs to know that before touching it.

Inside the inner wall sits the matrix — the soup where the Krebs cycle runs and mitochondrial DNA lives. The Krebs cycle loads electrons onto NADH, which then feeds the electron transport chain. The size of your NAD pool sets the ceiling on how fast that cycle can run, and the pool shrinks with age, poor sleep, and chronic inflammation. That's the whole rationale behind NAD+ or NMN supplementation — refilling the substrate so the Krebs cycle isn't bottlenecked. Glutathione, meanwhile, is the buffer that protects mitochondrial DNA from the oxidative damage that happens in this same soup — relevant any time you're running high mitochondrial throughput, whether that's an intense training block or an active NAD+/MOTS-c stack.

Last piece: mitochondria aren't permanent. Cells constantly demolish damaged units (mitophagy) and build new ones (biogenesis). Urolithin A — a compound your gut bacteria make from pomegranate, walnut, and berry compounds, though only about 40% of people convert it efficiently on their own — supports the demolition side. The construction side runs through a master switch called PGC1-α, and multiple unrelated interventions converge on activating it: exercise (the strongest known activator, full stop), fasting, cold exposure, NAD+ replenishment, and MOTS-c, which drives the same AMPK → SIRT1 → PGC1-α pathway — the molecular reason people call it an "exercise mimetic." These aren't redundant. They're synergistic, because they all converge on the same downstream switch through different upstream doors.

Why exercise beats every supplement on the shelf

Here's the one claim in this whole article I want you to actually remember: exercise is the single most powerful lever for mitochondrial structure, and nothing sold in a bottle or a vial comes close to it at the cristae-remodeling and biogenesis layer. This isn't a polite nod to "diet and exercise matter." The foundational data goes back to 1967, when 12 weeks of treadmill training in rats doubled oxidative enzyme activity in skeletal muscle — and that finding has been replicated and extended in the decades since. Trained muscle has denser, better-organized cristae than untrained muscle. No pill does that.

This is why my sequencing advice never changes: foundation first, then adjuncts, then peptides. Training, sleep, and a diet that supplies membrane-building phospholipids come first. CoQ10 (non-negotiable if you're on a statin), omega-3, and an NAD+ precursor come next. MOTS-c, SS-31, and NAD+ injectables are the amplification layer on top. Run the peptide layer without the foundation and you're not amplifying a healthy system — you're adding demand to one that's already misfiring. That's the customer who tries MOTS-c, feels nothing, or feels worse, and blames the peptide. The peptide did its job. There was nothing underneath to amplify.

The nuance worth knowing: ROS isn't the enemy

One thing that trips people up once they start reading about mitochondria: they assume the goal is zero oxidative stress. It isn't. About 1–2% of the oxygen moving through the electron transport chain leaks out as reactive oxygen species (ROS) — mostly at complex I and III — and a controlled amount of that is normal and useful. It's called mitohormesis: small, regulated ROS exposure (like the spike you get during a hard workout) trains the system to become more resilient. The problem is chronic, unregulated ROS from bad sleep, constant inflammation, or a sedentary lifestyle — not ROS itself. That's also why blasting high-dose antioxidants around your workouts can backfire: some research suggests it blunts the very adaptive response exercise is trying to produce. The better frame is supporting your body's own antioxidant systems (glutathione precursors, selenium, vitamin C and E) and reducing the upstream stressors, not carpet-bombing with supplements.

Honest limits

A few places worth flagging so you know where the science is solid versus where it's still being worked out. The "exercise beats supplements" claim is well-supported for biogenesis and cristae remodeling specifically — head-to-head human comparisons against the newest injectable interventions haven't been run. The 5-part map above is a teaching tool, not a diagnostic test — real dysfunction is usually spread across more than one sub-system, and figuring out your actual rate-limiting step is still part art, part trial and error. And if you have a diagnosed primary mitochondrial disorder or a genetic condition affecting the electron transport chain, this article is not a substitute for working with a clinician who understands that specific biology.

The empowering version of all this: you can absolutely do something about your mitochondrial health. You just need to fix the part that's actually broken, in the right order.

-- Rick

Sources: Holloszy JO, J Biol Chem 1967;242(9):2278-2282 (foundational exercise-biogenesis paper) · Memme et al., J Physiol 2021;599(3):803-817, DOI 10.1113/JP278853 (exercise and mitochondrial quality control review) · Horvath & Daum, Prog Lipid Res 2013;52(4):590-614, PMID 24007978 (mitochondrial membrane lipid composition) · Murphy MP, Biochem J 2009;417(1):1-13, PMID 19061483 (ROS production mechanism) · Mortensen et al., JACC Heart Fail 2014;2(6):641-649, PMID 25282031 (Q-SYMBIO CoQ10 trial) · Andreux et al., Nat Metab 2019;1:595-603, DOI 10.1038/s42255-019-0073-4 (urolithin A human trial) · Zhang et al., Nature 2010;464(7285):104-107, PMID 20303168 (mitochondrial DAMPs and inflammatory signaling). See also the MOTS-c and SS-31 deep-dive articles for dosing, cycling, and vendor detail.

Educational information only, not medical advice. Peptides discussed here are sold for research use only and are not FDA-approved for human use except where noted.